JENNAGRACE EARNEST: Open Payments
NPI 1194142703 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 27 payments from 10 companies in 2025. Trend: 2023 $234 · 2024 $263 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $177 |
| MILLICENT US INC | 4 | $66 |
| Exeltis, USA Inc. | 4 | $62 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $47 |
| ABBVIE INC. | 2 | $41 |
| Ardelyx, Inc. | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Organon LLC | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: Veozah, SLYND, FEMRING, INTRAROSA, IBSRELA, MYOSURE TISSUE REMOVAL DEVICE, QULIPTA, LILETTA.
Industry payments across MS — which companies pay providers there.
